Prevention of tuberculosis in HIV-1

Saved in:
Bibliographic Details
Published in:The Lancet (British edition) 1998-08, Vol.352 (9129), p.742-742
Main Authors: Halsey, Neal A, Coberly, Jacqueline, Chaisson, Richard
Format: Article
Language:English
Subjects:
AIDS-Related Opportunistic Infections - prevention & control
AIDS/HIV
Antitubercular Agents - therapeutic use
Drug Resistance, Microbial
HIV-1
Humans
Isoniazid - therapeutic use
Mycobacterium tuberculosis - drug effects
Pyrazinamide - therapeutic use
Rifampin - therapeutic use
Tuberculosis - prevention & control
Citations: Items that this one cites
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by
cites cdi_FETCH-LOGICAL-c382t-91a9fc43aed70b7f7479342d4fc9cefe24015ddd619ef4ac615ac17c0356d6513
container_end_page 742
container_issue 9129
container_start_page 742
container_title The Lancet (British edition)
container_volume 352
creator Halsey, Neal A
Coberly, Jacqueline
Chaisson, Richard
description
doi_str_mv 10.1016/S0140-6736(05)60866-5
format article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_73910344</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0140673605608665</els_id><sourcerecordid>73910344</sourcerecordid><originalsourceid>FETCH-LOGICAL-c382t-91a9fc43aed70b7f7479342d4fc9cefe24015ddd619ef4ac615ac17c0356d6513</originalsourceid><addsrcrecordid>eNqFkMtKw0AUhgdRaq0-QiEoiC6iZzI3ZyVS1BYKCl5wN6QzJzAlTepMUvDtTS904cbVWfy3w0fIkMINBSpv34BySKVi8grEtYQ7KVNxQPqUK54Krr4OSX9vOSYnMc4BgEsQPdLTKtOQyT65eA24wqrxdZXURdK0Mwy2LevoY-KrZDz5TOkpOSryMuLZ7g7Ix9Pj-2icTl-eJ6OHaWrZXdakmua6sJzl6BTMVKG40oxnjhdWWyww40CFc05SjQXPraQit1RZYEI6KSgbkMtt7zLU3y3Gxix8tFiWeYV1G41imgLjvDOe_zHO6zZU3W-Gat2tsGzdJrYmG-oYAxZmGfwiDz-GglkTNBuCZo3HgDAbgkZ0ueGuvJ0t0O1TO2Sdfr_VsUOx8hhMtB4ri84HtI1xtf9n4RdXG32e</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>199015321</pqid></control><display><type>article</type><title>Prevention of tuberculosis in HIV-1</title><source>Business Source Ultimate</source><source>ScienceDirect Freedom Collection</source><creator>Halsey, Neal A ; Coberly, Jacqueline ; Chaisson, Richard</creator><creatorcontrib>Halsey, Neal A ; Coberly, Jacqueline ; Chaisson, Richard</creatorcontrib><identifier>ISSN: 0140-6736</identifier><identifier>EISSN: 1474-547X</identifier><identifier>DOI: 10.1016/S0140-6736(05)60866-5</identifier><identifier>PMID: 9729026</identifier><identifier>CODEN: LANCAO</identifier><language>eng</language><publisher>England: Elsevier Ltd</publisher><subject>AIDS-Related Opportunistic Infections - prevention &amp; control ; AIDS/HIV ; Antitubercular Agents - therapeutic use ; Drug Resistance, Microbial ; HIV-1 ; Humans ; Isoniazid - therapeutic use ; Mycobacterium tuberculosis - drug effects ; Pyrazinamide - therapeutic use ; Rifampin - therapeutic use ; Tuberculosis - prevention &amp; control</subject><ispartof>The Lancet (British edition), 1998-08, Vol.352 (9129), p.742-742</ispartof><rights>1998 Elsevier Ltd</rights><rights>Copyright National Library of Medicine - MEDLINE Abstracts Aug 29 1998</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><cites>FETCH-LOGICAL-c382t-91a9fc43aed70b7f7479342d4fc9cefe24015ddd619ef4ac615ac17c0356d6513</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,776,780,27903,27904</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/9729026$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Halsey, Neal A</creatorcontrib><creatorcontrib>Coberly, Jacqueline</creatorcontrib><creatorcontrib>Chaisson, Richard</creatorcontrib><title>Prevention of tuberculosis in HIV-1</title><title>The Lancet (British edition)</title><addtitle>Lancet</addtitle><subject>AIDS-Related Opportunistic Infections - prevention &amp; control</subject><subject>AIDS/HIV</subject><subject>Antitubercular Agents - therapeutic use</subject><subject>Drug Resistance, Microbial</subject><subject>HIV-1</subject><subject>Humans</subject><subject>Isoniazid - therapeutic use</subject><subject>Mycobacterium tuberculosis - drug effects</subject><subject>Pyrazinamide - therapeutic use</subject><subject>Rifampin - therapeutic use</subject><subject>Tuberculosis - prevention &amp; control</subject><issn>0140-6736</issn><issn>1474-547X</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>1998</creationdate><recordtype>article</recordtype><recordid>eNqFkMtKw0AUhgdRaq0-QiEoiC6iZzI3ZyVS1BYKCl5wN6QzJzAlTepMUvDtTS904cbVWfy3w0fIkMINBSpv34BySKVi8grEtYQ7KVNxQPqUK54Krr4OSX9vOSYnMc4BgEsQPdLTKtOQyT65eA24wqrxdZXURdK0Mwy2LevoY-KrZDz5TOkpOSryMuLZ7g7Ix9Pj-2icTl-eJ6OHaWrZXdakmua6sJzl6BTMVKG40oxnjhdWWyww40CFc05SjQXPraQit1RZYEI6KSgbkMtt7zLU3y3Gxix8tFiWeYV1G41imgLjvDOe_zHO6zZU3W-Gat2tsGzdJrYmG-oYAxZmGfwiDz-GglkTNBuCZo3HgDAbgkZ0ueGuvJ0t0O1TO2Sdfr_VsUOx8hhMtB4ri84HtI1xtf9n4RdXG32e</recordid><startdate>19980829</startdate><enddate>19980829</enddate><creator>Halsey, Neal A</creator><creator>Coberly, Jacqueline</creator><creator>Chaisson, Richard</creator><general>Elsevier Ltd</general><general>Elsevier Limited</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7QL</scope><scope>7QP</scope><scope>7TK</scope><scope>7U7</scope><scope>7U9</scope><scope>ASE</scope><scope>C1K</scope><scope>FPQ</scope><scope>H94</scope><scope>K6X</scope><scope>K9.</scope><scope>KB~</scope><scope>M7N</scope><scope>NAPCQ</scope><scope>7X8</scope></search><sort><creationdate>19980829</creationdate><title>Prevention of tuberculosis in HIV-1</title><author>Halsey, Neal A ; Coberly, Jacqueline ; Chaisson, Richard</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c382t-91a9fc43aed70b7f7479342d4fc9cefe24015ddd619ef4ac615ac17c0356d6513</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>1998</creationdate><topic>AIDS-Related Opportunistic Infections - prevention &amp; control</topic><topic>AIDS/HIV</topic><topic>Antitubercular Agents - therapeutic use</topic><topic>Drug Resistance, Microbial</topic><topic>HIV-1</topic><topic>Humans</topic><topic>Isoniazid - therapeutic use</topic><topic>Mycobacterium tuberculosis - drug effects</topic><topic>Pyrazinamide - therapeutic use</topic><topic>Rifampin - therapeutic use</topic><topic>Tuberculosis - prevention &amp; control</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Halsey, Neal A</creatorcontrib><creatorcontrib>Coberly, Jacqueline</creatorcontrib><creatorcontrib>Chaisson, Richard</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Bacteriology Abstracts (Microbiology B)</collection><collection>Calcium &amp; Calcified Tissue Abstracts</collection><collection>Neurosciences Abstracts</collection><collection>Toxicology Abstracts</collection><collection>Virology and AIDS Abstracts</collection><collection>British Nursing Index</collection><collection>Environmental Sciences and Pollution Management</collection><collection>British Nursing Index (BNI) (1985 to Present)</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>British Nursing Index</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>ProQuest Newsstand Professional</collection><collection>Algology Mycology and Protozoology Abstracts (Microbiology C)</collection><collection>Nursing &amp; Allied Health Premium</collection><collection>MEDLINE - Academic</collection><jtitle>The Lancet (British edition)</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Halsey, Neal A</au><au>Coberly, Jacqueline</au><au>Chaisson, Richard</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Prevention of tuberculosis in HIV-1</atitle><jtitle>The Lancet (British edition)</jtitle><addtitle>Lancet</addtitle><date>1998-08-29</date><risdate>1998</risdate><volume>352</volume><issue>9129</issue><spage>742</spage><epage>742</epage><pages>742-742</pages><issn>0140-6736</issn><eissn>1474-547X</eissn><coden>LANCAO</coden><cop>England</cop><pub>Elsevier Ltd</pub><pmid>9729026</pmid><doi>10.1016/S0140-6736(05)60866-5</doi><tpages>1</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 0140-6736
ispartof The Lancet (British edition), 1998-08, Vol.352 (9129), p.742-742
issn 0140-6736
1474-547X
language eng
recordid cdi_proquest_miscellaneous_73910344
source Business Source Ultimate; ScienceDirect Freedom Collection
subjects AIDS-Related Opportunistic Infections - prevention & control
AIDS/HIV
Antitubercular Agents - therapeutic use
Drug Resistance, Microbial
HIV-1
Humans
Isoniazid - therapeutic use
Mycobacterium tuberculosis - drug effects
Pyrazinamide - therapeutic use
Rifampin - therapeutic use
Tuberculosis - prevention & control
title Prevention of tuberculosis in HIV-1
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-26T06%3A43%3A50IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Prevention%20of%20tuberculosis%20in%20HIV-1&rft.jtitle=The%20Lancet%20(British%20edition)&rft.au=Halsey,%20Neal%20A&rft.date=1998-08-29&rft.volume=352&rft.issue=9129&rft.spage=742&rft.epage=742&rft.pages=742-742&rft.issn=0140-6736&rft.eissn=1474-547X&rft.coden=LANCAO&rft_id=info:doi/10.1016/S0140-6736(05)60866-5&rft_dat=%3Cproquest_cross%3E73910344%3C/proquest_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c382t-91a9fc43aed70b7f7479342d4fc9cefe24015ddd619ef4ac615ac17c0356d6513%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=199015321&rft_id=info:pmid/9729026&rfr_iscdi=true